CNS Overzicht aandelen
Cohen & Steers, Inc. is een openbare holding voor vermogensbeheer.
Sneeuwvlok Score | |
---|---|
Waardering | 0/6 |
Toekomstige groei | 2/6 |
Prestaties in het verleden | 4/6 |
Financiële gezondheid | 5/6 |
Dividenden | 3/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Cohen & Steers, Inc. Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | US$98.04 |
52 Week Hoogtepunt | US$110.67 |
52 Week Laag | US$51.61 |
Bèta | 1.52 |
11 maand verandering | 4.00% |
3 maanden verandering | 18.35% |
1 Jaar Verandering | 75.95% |
33 jaar verandering | -1.82% |
5 jaar verandering | 49.20% |
Verandering sinds IPO | 654.15% |
Recent nieuws en updates
Recent updates
Some Shareholders Feeling Restless Over Cohen & Steers, Inc.'s (NYSE:CNS) P/E Ratio
Oct 17Cohen & Steers: Still Bullish After Assessing Q2 Results And AUM Figures
Jul 18Cohen & Steers, Inc.'s (NYSE:CNS) Shares May Have Run Too Fast Too Soon
Jul 16Cohen & Steers: Eyes On Real Estate Recovery And Overseas Markets Growth
May 02Shareholders Will Most Likely Find Cohen & Steers, Inc.'s (NYSE:CNS) CEO Compensation Acceptable
Apr 26Cohen & Steers, Inc.'s (NYSE:CNS) Share Price Not Quite Adding Up
Apr 01Cohen & Steers: Dependence On Real Estate, Still Not Buying It
Feb 16Getting In Cheap On Cohen & Steers, Inc. (NYSE:CNS) Is Unlikely
Dec 19Cohen & Steers: The Issue Is Real Estate
Nov 28Cohen & Steers: Focus On Asia Expansion And Cost Management (Rating Upgrade)
Sep 10Cohen & Steers: It's All About Real Estate
Jun 27Cohen & Steers AUM up 8.5% in January on net inflows, market appreciation
Feb 08Cohen & Steers: Best Near-Term Investment Management Capital Gain Prospect
Feb 03Cohen & Steers AUM down 4.5% sequentially in December on market depreciation
Jan 10Cohen & Steers AUM rises to $84.2B in November on market appreciation
Dec 08Cohen & Steers reports prelim AUM for Oct
Nov 08The Cohen & Steers, Inc. (NYSE:CNS) Analyst Just Cut Their Revenue Forecast By 15%
Oct 20Cohen & Steers Q3 2022 Earnings Preview
Oct 18Cohen & Steers AUM falls to $79.2B on market depreciation, net outflows
Oct 10Rendement voor aandeelhouders
CNS | US Capital Markets | US Markt | |
---|---|---|---|
7D | -2.5% | -1.8% | -1.6% |
1Y | 76.0% | 49.0% | 30.8% |
Rendement versus industrie: CNS exceeded the US Capital Markets industry which returned 49% over the past year.
Rendement versus markt: CNS exceeded the US Market which returned 30.8% over the past year.
Prijsvolatiliteit
CNS volatility | |
---|---|
CNS Average Weekly Movement | 3.6% |
Capital Markets Industry Average Movement | 3.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: CNS has not had significant price volatility in the past 3 months compared to the US market.
Volatiliteit in de loop van de tijd: CNS's weekly volatility (4%) has been stable over the past year.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
1986 | 405 | Joe Harvey | www.cohenandsteers.com |
Cohen & Steers, Inc. is een openbare holding voor vermogensbeheer. Via haar dochterondernemingen levert het bedrijf diensten aan institutionele beleggers, waaronder pensioenfondsen, schenkingen en stichtingen. Via haar dochterondernemingen beheert zij afzonderlijke klantgerichte aandelen-, vastrentende, multi-asset en grondstoffenportefeuilles.
Cohen & Steers, Inc. Samenvatting
CNS fundamentele statistieken | |
---|---|
Marktkapitalisatie | US$4.96b |
Inkomsten(TTM) | US$135.26m |
Inkomsten(TTM) | US$496.82m |
36.6x
Koers/Winstverhouding10.0x
P/S-verhoudingIs CNS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
CNS resultatenrekening (TTM) | |
---|---|
Inkomsten | US$496.82m |
Kosten van inkomsten | US$265.42m |
Brutowinst | US$231.41m |
Overige uitgaven | US$96.15m |
Inkomsten | US$135.26m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | 2.68 |
Brutomarge | 46.58% |
Nettowinstmarge | 27.23% |
Schuld/Eigen Vermogen Verhouding | 24.2% |
Hoe presteerde CNS op de lange termijn?
Bekijk historische prestaties en vergelijking